Procurement Summary
Country : USA
Summary : Neuronext Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Deadline : 05 Apr 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 52846998
Document Ref. No. : PAR-21-224
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Tender are invited for NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Apr 05, 2024
Posted Date : May 05, 2021
Description: This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).
Documents
Tender Notice